We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

30 hedge funds and large institutions have $104M invested in Tempest Therapeutics in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

96% more capital invested

Capital invested by funds: $53.2M → $104M (+$51.1M)

0% more funds holding

Funds holding: 30 → 30 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

Holders
30
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
9
Increased
7
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.73M
2
IBT
International Biotechnology Trust
United Kingdom
+$701K
3
Millennium Management
Millennium Management
New York
+$566K
4
TEE
Tibra Equities Europe
United Kingdom
+$230K
5
Renaissance Technologies
Renaissance Technologies
New York
+$168K

Top Sellers

Rank Fund Capital Flow
1
TFCP
Twin Focus Capital Partners
Massachusetts
-$515K
2
GC
GMT Capital
Georgia
-$445K
3
WVP
Worth Venture Partners
New Jersey
-$86.3K
4
TAM
Tiverton Asset Management
Delaware
-$13K
5
Wells Fargo
Wells Fargo
California
-$11.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
26
Lindbrook Capital
California
$15K +$11.1K +5 New
Wells Fargo
27
Wells Fargo
California
$11K -$11.1K -5 -56%
CSS
28
Cubist Systematic Strategies
Connecticut
$11K +$8.85K +4 New
JP Morgan Chase
29
JP Morgan Chase
New York
$10K +$4.42K +2 +200%
Federated Hermes
30
Federated Hermes
Pennsylvania
$2K – – –
Bank of America
31
Bank of America
North Carolina
$1K – – –
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$1K – – –
BWM
33
Baystate Wealth Management
Massachusetts
$1K – – –
TCOV
34
Trust Company of Vermont
Vermont
$1K – – –
RE
35
RBC Europe
United Kingdom
$90 – – –
TFCP
36
Twin Focus Capital Partners
Massachusetts
– -$515K -332 Closed
TAM
37
Tiverton Asset Management
Delaware
– -$13K -8 Closed
UBS Group
38
UBS Group
Switzerland
– -$11K -7 Closed
TRCT
39
Tower Research Capital (TRC)
New York
– -$7K -4 Closed
PAM
40
Panagora Asset Management
Massachusetts
– -$5K -3 Closed
GHCM
41
Glen Harbor Capital Management
California
– -$3K -2 Closed
MCIM
42
Meadow Creek Investment Management
Georgia
– -$3K -2 Closed
EP
43
Elkfork Partners
Oregon
– -$2K -1 Closed
TAM
44
Tyers Asset Management
Texas
– -$2K -1 Closed
1
2

TPST Hedge Fund Activity: Q1 2019 in Review

30 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2019, worth a combined $104M — up 96% from $53.2M a quarter earlier.

Fund positioning in TPST was balanced in Q1 2019: 9 funds opened new positions, 9 closed out, 7 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.73M. The largest seller was Twin Focus Capital Partners, exiting entirely with an estimated $515K sold.

  • 30 institutional investors held Tempest Therapeutics (TPST) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $104M of Tempest Therapeutics stock for Q1 2019, up 96% quarter-over-quarter.
  • 9 funds opened new Tempest Therapeutics positions in Q1 2019 and 9 closed out, a net change of 0 holders.
  • The largest Tempest Therapeutics buyer in Q1 2019 was Vanguard Group, an estimated $1.73M added.
  • The largest Tempest Therapeutics seller in Q1 2019 was Twin Focus Capital Partners, an estimated $515K sold.

Based on aggregated 13F filings for Q1 2019.